WANBURY
Back to All Ratios
|
WANBURY Last 5 Year EV/Net Sales History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/Net Sales(x) | 1.01 | 0.36 | 0.62 | 0.91 | 0.52 |
What is the latest EV/Net Sales ratio of WANBURY ?
Year | EV/Net Sales |
---|---|
Mar2024 | 1.01 |
Mar2023 | 0.36 |
Mar2022 | 0.62 |
Mar2021 | 0.91 |
Mar2020 | 0.52 |
How is EV/Net Sales of WANBURY Trending?
Years | EV/Net Sales | % Change | |
---|---|---|---|
Mar2024 | 1.01 | 180.56 | |
Mar2023 | 0.36 | -41.94 | |
Mar2022 | 0.62 | -31.87 | |
Mar2021 | 0.91 | 75.00 | |
Mar2020 | 0.52 | - |
Other Financial Ratios of WANBURY
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Net Sales ratio of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹748.2 Cr | 5.4% | -13.3% | 41.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 5.4% |
-13.3% |
41.2% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses